Mednax Total Current Assets from 2010 to 2026

MD Stock  USD 21.52  0.45  2.14%   
Mednax's Total Current Assets are increasing over the years with slightly volatile fluctuation. Total Current Assets are expected to dwindle to about 404.4 M. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
1994-12-31
Previous Quarter
613 M
Current Value
717.2 M
Quarterly Volatility
287.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.8 M, Interest Expense of 25.2 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 1.56. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
  
Build AI portfolio with Mednax Stock
Check out the analysis of Mednax Correlation against competitors.
Analyzing Mednax's Total Current Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Total Current Assets has evolved provides context for assessing Mednax's current valuation and future prospects.

Latest Mednax's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Mednax Inc over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Mednax's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Mednax Total Current Assets Regression Statistics

Arithmetic Mean576,553,018
Geometric Mean460,825,287
Coefficient Of Variation54.83
Mean Deviation206,579,047
Median527,769,000
Standard Deviation316,110,985
Sample Variance99926.2T
Range1.5B
R-Value0.42
Mean Square Error87694.2T
R-Squared0.18
Significance0.09
Slope26,355,651
Total Sum of Squares1598818.5T

Mednax Total Current Assets History

2026404.4 M
2025735.5 M
2024639.6 M
2023483.5 M
2022428 M
2021840.6 M
20201.5 B

About Mednax Financial Statements

Mednax stakeholders use historical fundamental indicators, such as Mednax's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Mednax investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednax's assets and liabilities are reflected in the revenues and expenses on Mednax's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednax Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets735.5 M404.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Mednax Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
2.652
Earnings Share
1.91
Revenue Per Share
22.778
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0686
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value - what Mednax's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.